Publications

Finger RP, Ayton LN, Deverell L, O'Hare F, McSweeney SC, Luu CD, Fenwick EK, Keeffe JE, Guymer RH, Bentley SA. Developing a Very Low Vision Orientation and Mobility Test Battery (O&M-VLV). Optom Vis Sci. 2016 Sep;93(9):1127-36.

Finger RP, McSweeney SC, Deverell L, O'Hare F, Bentley SA, Luu CD, Guymer RH, Ayton LN. Developing an instrumental activities of daily living tool as part of the low vision assessment of daily activities protocol. Invest Ophthalmol Vis Sci. 2014 Nov 25;55(12):8458-66. 

Finger RP, Tellis B, Crewe J, Keeffe JE, Ayton LN, Guymer RH. Developing the impact of Vision Impairment-Very Low Vision (IVI-VLV) questionnaire as part of the LoVADA protocol. Invest Ophthalmol Vis Sci. 2014 Sep 4;55(10):6150-8. 

Fenwick EK, O'Hare F, Deverell L, Ayton LN, Luu CD, McSweeney S, Bentley SA, Guymer RH, Finger RP. Rasch Analysis of the Independent Mobility Questionnaire. Optom Vis Sci. 2016 Feb;93(2):181-7. 

Chen G, Finger RP, Holloway EE, Iezzi A, Richardson J. Estimating Utility Weights for the Vision Related Quality of Life Index. Optom Vis Sci. 2016 Dec;93(12):1495-1501. 

Finger RP, Guymer RH, Gillies MC, Keeffe JE. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration. Ophthalmology. 2014 Jun;121(6):1246-51. 

Finger RP, Fenwick E, Hirneiss CW, Hsueh A, Guymer RH, Lamoureux EL, Keeffe JE. Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences. PLoS One. 2013 Dec 5;8(12):e81042. 

Finger RP, Fenwick E, Pesudovs K, Marella M, Lamoureux EL, Holz FG. Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire. Ophthalmology. 2012 Nov;119(11):2351-7. 

Finger RP, Hoffmann AE, Fenwick EK, Wolf A, Kampik A, Kernt M, Neubauer AS, Hirneiss C. Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine. Br J Ophthalmol. 2012 Jul;96(7):997-1002.